IL118469A - Naphthalene derivatives their preparation and intermediates thereof - Google Patents

Naphthalene derivatives their preparation and intermediates thereof

Info

Publication number
IL118469A
IL118469A IL11846996A IL11846996A IL118469A IL 118469 A IL118469 A IL 118469A IL 11846996 A IL11846996 A IL 11846996A IL 11846996 A IL11846996 A IL 11846996A IL 118469 A IL118469 A IL 118469A
Authority
IL
Israel
Prior art keywords
intermediates
preparation
naphthalene derivatives
naphthalene
derivatives
Prior art date
Application number
IL11846996A
Other languages
English (en)
Other versions
IL118469A0 (en
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of IL118469A0 publication Critical patent/IL118469A0/xx
Publication of IL118469A publication Critical patent/IL118469A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL11846996A 1995-06-15 1996-05-30 Naphthalene derivatives their preparation and intermediates thereof IL118469A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14928895 1995-06-15

Publications (2)

Publication Number Publication Date
IL118469A0 IL118469A0 (en) 1996-09-12
IL118469A true IL118469A (en) 2000-08-13

Family

ID=15471914

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11846996A IL118469A (en) 1995-06-15 1996-05-30 Naphthalene derivatives their preparation and intermediates thereof

Country Status (21)

Country Link
US (3) US6005106A (es)
EP (1) EP0748805B1 (es)
KR (1) KR100435247B1 (es)
CN (1) CN1063748C (es)
AR (1) AR002483A1 (es)
AT (1) ATE164843T1 (es)
AU (1) AU706156B2 (es)
BG (1) BG62521B1 (es)
BR (1) BR9602802A (es)
CA (1) CA2178974C (es)
DE (1) DE69600221T2 (es)
ES (1) ES2116131T3 (es)
HK (1) HK1010116A1 (es)
HU (1) HU222340B1 (es)
IL (1) IL118469A (es)
MY (1) MY121606A (es)
NO (1) NO310109B1 (es)
RU (1) RU2129120C1 (es)
SG (1) SG47152A1 (es)
TW (1) TW349098B (es)
ZA (1) ZA964652B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
JPH1171351A (ja) * 1997-08-29 1999-03-16 Ss Pharmaceut Co Ltd 置換キノロン誘導体及びこれを含有する医薬
US20050147534A1 (en) 1998-05-05 2005-07-07 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
WO1999057222A1 (en) 1998-05-05 1999-11-11 Massachusetts Institute Of Technology Emissive polymers and devices incorporating these polymers
CN1520313A (zh) * 2001-05-23 2004-08-11 ������ҩ��ʽ���� 一种加速骨折愈合的组合物
CA2447618A1 (en) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. A composition for regenerative treatment of cartilage disease
TWI221838B (en) 2001-08-09 2004-10-11 Tanabe Seiyaku Co Pyrazinoisoquinoline compound or naphthalene compound
EP1463714A4 (en) * 2001-12-10 2005-10-19 Amgen Inc VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
WO2003057689A1 (en) * 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
PL375552A1 (en) * 2002-05-22 2005-11-28 Amgen Inc. Vanilloid receptor ligands and their medical applications
EP1717220A3 (en) * 2002-08-08 2007-08-22 Amgen, Inc Vanilloid receptor ligands and their use in treatments
CA2517888C (en) 2003-03-14 2012-05-01 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
BRPI0409229A (pt) 2003-04-01 2006-03-28 Applied Research Systems inibidores das fosfodiesterases na infertilidade
KR20060030467A (ko) * 2003-05-16 2006-04-10 더 유니버시티 오브 시카고 광학 분류 방법 및 장치
EP1670794A2 (en) * 2003-09-30 2006-06-21 Amgen Inc. Vanilloid receptor ligands and their use in treatments
WO2005077938A1 (en) 2004-02-11 2005-08-25 Amgen Inc. Vanilloid receptor ligands and their use in treatments
MY139645A (en) * 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
RU2409565C2 (ru) 2004-09-13 2011-01-20 Оно Фармасьютикал Ко., Лтд. Азотистые гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
US8617819B2 (en) 2004-09-17 2013-12-31 Massachusetts Institute Of Technology Polymers for analyte detection
TWI339578B (en) 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
WO2006089311A1 (en) * 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
WO2007040238A1 (ja) 2005-10-04 2007-04-12 Mitsubishi Tanabe Pharma Corporation 光学活性4-ヒドロキシ-1,2,3,4-テトラヒドロキノリン化合物の製法
PT1944291E (pt) 2005-10-04 2012-08-10 Mitsubishi Tanabe Pharma Corp Álcool cíclico opticamente activo e método para a sua produção
JP4767968B2 (ja) * 2005-10-05 2011-09-07 田辺三菱製薬株式会社 皮膚炎治療剤
JPWO2007105637A1 (ja) 2006-03-10 2009-07-30 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2007112347A1 (en) * 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8283423B2 (en) 2006-09-29 2012-10-09 Massachusetts Institute Of Technology Polymer synthetic technique
US8802447B2 (en) 2006-10-05 2014-08-12 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US20090215189A1 (en) 2006-10-27 2009-08-27 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
EP1958947A1 (en) * 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
JP2010524857A (ja) * 2007-04-10 2010-07-22 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア フェン−ナフタレン及びフェン−キノリン誘導体、及びアミロイドプラークに結合させ、そして造影するための使用
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
ES2659458T3 (es) * 2011-06-28 2018-03-15 Mitsubishi Tanabe Pharma Corporation Compuestos de naftaleno para tratar el prurito
US9181217B2 (en) 2011-08-25 2015-11-10 Mitsubishi Tanabe Pharma Corporation Method for producing optically active naphthalene compound
US11970440B1 (en) 2023-10-30 2024-04-30 King Faisal University 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11932593B1 (en) 2023-10-31 2024-03-19 King Faisal University 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11987543B1 (en) 2023-10-31 2024-05-21 King Faisal University 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3042156B2 (ja) * 1992-02-20 2000-05-15 田辺製薬株式会社 ナフタレン誘導体、その製法及びその合成中間体
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
DE59609705D1 (de) * 1995-03-03 2002-10-31 Rolic Ag Zug Photovernetzbare Naphthylderivate

Also Published As

Publication number Publication date
HU9601652D0 (en) 1996-08-28
ATE164843T1 (de) 1998-04-15
DE69600221T2 (de) 1998-08-06
CN1063748C (zh) 2001-03-28
CN1142497A (zh) 1997-02-12
US6214996B1 (en) 2001-04-10
HK1010116A1 (en) 1999-06-11
TW349098B (en) 1999-01-01
ES2116131T3 (es) 1998-07-01
AU5469396A (en) 1997-01-02
KR100435247B1 (ko) 2004-09-10
CA2178974A1 (en) 1996-12-16
BG62521B1 (bg) 2000-01-31
NO310109B1 (no) 2001-05-21
ZA964652B (en) 1996-12-12
US6005106A (en) 1999-12-21
HUP9601652A1 (en) 1997-09-29
NO962527L (no) 1996-12-16
CA2178974C (en) 2006-06-06
SG47152A1 (en) 1998-03-20
MY121606A (en) 2006-02-28
EP0748805A1 (en) 1996-12-18
DE69600221D1 (de) 1998-05-14
BG100656A (en) 1997-09-30
NO962527D0 (no) 1996-06-14
KR970001343A (ko) 1997-01-24
BR9602802A (pt) 1998-10-06
US5969140A (en) 1999-10-19
AR002483A1 (es) 1998-03-25
RU2129120C1 (ru) 1999-04-20
HU222340B1 (hu) 2003-06-28
AU706156B2 (en) 1999-06-10
IL118469A0 (en) 1996-09-12
EP0748805B1 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
IL118469A0 (en) Naphthalene derivatives their preparation and intermediates thereof
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
KR19987002466A (en) Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
ZA966494B (en) New drugs and their use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL118380A0 (en) Substituted pyridine derivatives their preparation and use
IL122216A0 (en) Dolastatin derivatives their preparation and use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL118295A0 (en) 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL116712A0 (en) Substituted 2-phenylpyridines their preparation and use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL122342A0 (en) Retinoid derivatives and their use
AU4459196A (en) Sustained-release preparation and use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
EP0833835A4 (en) OBESITY PROTEIN INTERMEDIATE PRODUCTS, THEIR PRODUCTION AND USE
GR3033729T3 (en) Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired